Pharos iBio Co., Ltd. Logo

Pharos iBio Co., Ltd.

Clinical-stage biotech using AI to develop therapies for rare diseases and cancer.

388870 | KO

Overview

Corporate Details

ISIN(s):
KR7388870008
LEI:
Country:
South Korea
Address:
경기도 안양시 동안구 흥안대로427번길 38, 1408호(관양동, 성지스타위드), 안양시

Description

Pharos iBio is a clinical-stage biotechnology company that specializes in drug discovery and development. The company leverages a proprietary platform based on artificial intelligence (AI) and big data to identify and create novel therapeutic candidates. Its primary focus is on developing treatments for rare and refractory diseases, with a significant emphasis on oncology. The development pipeline includes assets that are progressing through clinical trials, such as a therapy for acute myeloid leukemia.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-13 00:00
반기보고서 (2025.06)
Korean 1.2 MB
2025-07-21 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB
2025-07-16 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB
2025-06-30 00:00
투자판단관련주요경영사항(임상시험결과) (경구용 항암제 PHI101의 임상 1상 임상시험결과보고서(CSR) 수령)
Korean 14.4 KB
2025-06-26 00:00
[기재정정]투자판단관련주요경영사항(임상시험계획승인신청등결정) (BRAF, KRAS 또는 NRAS 돌연변이를 가진 진행성…
Korean 15.8 KB
2025-06-25 00:00
투자판단관련주요경영사항(임상시험계획승인신청등결정) (BRAF, KRAS 또는 NRAS 돌연변이를 가진 진행성 고형암 환…
Korean 12.3 KB
2025-05-15 00:00
분기보고서 (2025.03)
Korean 956.3 KB
2025-03-25 00:00
정기주주총회결과
Korean 25.3 KB
2025-03-25 00:00
주식매수선택권부여에관한신고
Korean 18.2 KB
2025-03-18 00:00
사업보고서 (2024.12)
Korean 364.5 KB
2025-03-17 00:00
감사보고서제출
Korean 26.0 KB
2025-03-07 00:00
주주총회소집공고
Korean 173.4 KB
2025-03-05 00:00
투자판단관련주요경영사항(임상시험계획승인신청) (BRAF, KRAS 또는 NRAS 돌연변이를 가진 진행성 고형암 환자를 …
Korean 9.3 KB
2025-02-10 00:00
주주총회소집결의
Korean 12.2 KB
2024-12-20 00:00
[기재정정]주식매수선택권부여에관한신고
Korean 18.2 KB

Automate Your Workflow. Get a real-time feed of all Pharos iBio Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Pharos iBio Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Pharos iBio Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.